Respiratory muscle weakness and inefficient ventilation in heart failure due to light-chain amyloidosis

References

• Kyle R A, Gertz M A. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Sem Hematol 1995; 32: 45–59
   PubMed Web of Science ®Google Scholar
• Gertz M A, Greipp P R, Kyle R A. Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow. J Lab Clin Med 1991; 118: 33–39
   PubMed Web of Science ®Google Scholar
• Saba N, Sutton D, Ross H, Siu S, Crump R, Keating A, Stewart A. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999; 24: 853–855
   PubMed Web of Science ®Google Scholar
• Perz J B, Kristen A V, Rahemtulla A, Parameshwar J, Sack F U, Apperley J F, Goldschmidt H, Katus H A, Dengler T J. Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation. Clin Res Cardiol 2006; 95: 1–4
   Google Scholar
• Kristen A V, Perz J B, Schonland S O, Hansen A, Hegenbart U, Sack F U, Goldschmidt H, Katus H A, Dengler T J. Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis. J Heart Lung Transplant 2007; 26: 1313–1319
   PubMed Web of Science ®Google Scholar
• Kristen A V, Meyer F J, Perz J B, Schonland S O, Hundemer M, Hegenbart U, Singer R, Schnabel P A, Sack F U, Goldschmidt H, Katus H A, Dengler T J. Risk stratification in cardiac amyloidosis: novel approaches. Transplantation 2005; 80: S151–S155
   PubMed Web of Science ®Google Scholar
• Kristen A V, Perz J, Schonland S, Hegenbart U, Schnabel P, Kristen J H, Goldschmidt H, Katus H A, Dengler T J. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007; 9: 617–624
   PubMed Web of Science ®Google Scholar
• Palladini G, Malamani G, Co F, Pistorio A, Recusani F, Anesi E, Garini P, Merlini G. Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clin Electrophysiol 2001; 24: 1228–1233
   PubMed Web of Science ®Google Scholar
• Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril G M, Moratti R, Merlini G. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003; 107: 2440–2445
   PubMed Web of Science ®Google Scholar
• Dispenzieri A, Kyle R A, Gertz M A, Therneau T M, Miller W L, Chandrasekaran K, McConnell J P, Burritt M F, Jaffe A S. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 2003; 361: 1787–1789
   PubMed Web of Science ®Google Scholar
• Mancini D M, Henson D, LaManca J, Levine S. Evidence of reduced respiratory muscle endurance in patients with heart failure. J Am Coll Cardiol 1994; 24: 972–981
   Google Scholar
• Witt C, Borges A C, Haake H, Reindl I, Kleber F X, Baumann G. Respiratory muscle weakness and normal ventilatory drive in dilative cardiomyopathy. Eur Heart J 1997; 18: 1322–1328
   PubMed Web of Science ®Google Scholar
• Meyer F J, Zugck C, Haass M, Otterspoor L, Strasser R H, Kubler W, Borst M M. Inefficient ventilation and reduced respiratory muscle capacity in congestive heart failure. Basic Res Cardiol 2000; 95: 333–342
   Google Scholar
• Opasich C, Ambrosino N, Felicetti G, Aquilani R, Pasini E, Bergitto D, Mazza A, Cobelli F, Tavazzi L. Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J 1999; 20: 1191–1200
   PubMed Web of Science ®Google Scholar
• McParland C, Krishnan B, Wang Y, Gallagher C G. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992; 146: 467–472
   PubMed Web of Science ®Google Scholar
• Kleber F X, Vietzke G, Wernecke K D, Bauer U, Opitz C, Wensel R, Sperfeld A, Glaser S. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000; 101: 2803–2809
   Google Scholar
• Meyer F J, Borst M M, Zugck C, Kirschke A, Schellberg D, Kubler W, Haass M. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 2001; 103: 2153–2158
   PubMed Web of Science ®Google Scholar
• Lavietes M H, Gerula C M, Fless K G, Cherniack N S, Arora R R. Inspiratory muscle weakness in diastolic dysfunction. Chest 2004; 126: 838–844
   Google Scholar
• Anonymous. Guidelines on the diagnosis and management of AL amyloidosis. Br J Haematol 2004; 125: 681–700
   Google Scholar
• Kristen A V, Dengler T J, Katus H A. Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard. Am J Hematol 2007; 82: 328
   Google Scholar
• Black L F, Hyatt R E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696–702
   PubMed Web of Science ®Google Scholar
• Quanjer P H. Lung function tests. Medicina 2003; 63: 459
   Google Scholar
• Anonymous. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002; 166: 518–624
   Google Scholar
• Lachmann H J, Hawkins P N. Amyloidosis and the lung. Chron Respir Dis 2006; 3: 203–214
   PubMedGoogle Scholar
• Gertz M A, Comenzo R, Falk R H, Fermand J P, Hazenberg B P, Hawkins P N, Merlini G, Moreau P, Ronco P, Sanchorawala V, Sezer O, Solomon A, Grateau G. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005; 79: 319–328
   PubMed Web of Science ®Google Scholar
• Khouri S J, Maly G T, Suh D D, Walsh T E. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 2004; 17: 290–297
   PubMed Web of Science ®Google Scholar
• Zile M R, Brutsaert D L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387–1393
   PubMed Web of Science ®Google Scholar
• Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel A S. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595–601
   PubMed Web of Science ®Google Scholar
• Hunt S A, Abraham W T, Chin M H, Feldman A M, Francis G S, Ganiats T G, Jessup M, Konstam M A, Mancini D M, Michl K, Oates J A, Rahko P S, Silver M A, Stevenson L W, Yancy C W, Antman E M, Smith S C, Jr, Adams C D, Anderson J L, Faxon D P, Fuster V, Halperin J L, Hiratzka L F, Jacobs A K, Nishimura R, Ornato J P, Page R L, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154–e235
   PubMed Web of Science ®Google Scholar
• Milic Emili J, Whitelaw W A, Derenne J P. New tests to assess lung function: occlusion pressure–a simple measure of the respiratory center's output. N Engl J Med 1975; 293: 1029–1030
   Google Scholar
• Meyer F J, Lossnitzer D, Kristen A V, Schoene A M, Kübler W, Katus H A, Borst M M. Respiratory Muscle Dysfunction in Idiopathic Pulmonary Arterial Hypertension. Eur Respir J 2005; 25: 1–6
   Google Scholar
• Bauer R, Dehnert C, Schoene P, Filusch A, Bartsch P, Borst M M, Katus H A, Joachim M F. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir Med 2007; 101: 2366–2369
   PubMed Web of Science ®Google Scholar
• Anker S D, Ponikowski P, Varney S, Chua T P, Clark A L, Webb Peploe K M, Harrington D, Kox W J, Poole Wilson P A, Coats A J. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050–1053
   PubMed Web of Science ®Google Scholar
• Lindsay D C, Lovegrove C A, Dunn M J, Bennett J G, Pepper J R, Yacoub M H, Poole Wilson P A. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996; 17: 1239–1250
   PubMed Web of Science ®Google Scholar
• Lecarpentier Y, Coirault C, Lerebours G, Desche P, Scalbert E, Lambert F, Chemla D. Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain. Am J Respir Crit Care Med 1997; 155: 630–636
   Google Scholar
• Sieck G C, Fournier M. Diaphragm motor unit recruitment during ventilatory and nonventilatory behaviors. J Appl Physiol 1989; 66: 2539–2545
   PubMed Web of Science ®Google Scholar
• Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1751–1759
   PubMed Web of Science ®Google Scholar
• Sullivan M J, Green H J, Cobb F R. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991; 84: 1597–1607
   PubMed Web of Science ®Google Scholar
• Granton J T, Naughton M T, Benard D C, Liu P P, Goldstein R S, Bradley T D. CPAP improves inspiratory muscle strength in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1996; 153: 277–282
   Google Scholar
• Hamilton A L, Killian K J, Summers E, Jones N L. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996; 110: 1255–1263
   PubMed Web of Science ®Google Scholar